Aliquots - Research Briefs

brain illustration
June 14, 2012

Roots of childhood brain tumors

Cells in the back of the developing brain can give rise to brain tumors, suggesting they may be a target for treatment.

By Leigh MacMillan
June 12, 2012

Making order out of ordinal data

A new statistical tool developed by Vanderbilt biostatisticians will help medical researchers make sense of a commonly encountered – but hard-to-analyze – type of data.

By Leigh MacMillan
June 8, 2012

DNA: From modification to mutation

Understanding how an environmental hazard damages DNA may shed light on processes of tumor formation.

By Leigh MacMillan
May 17, 2012

Long live the therapeutic stem cells

Enhancing stem cell survival is key to improving cell-based therapies for regenerative medicine, and a new drug could help.

By Leigh MacMillan
May 15, 2012

New clue to ADHD

A rare genetic change adds support to the idea that altered dopamine signaling is a key risk factor for ADHD.

By Bill Snyder
May 11, 2012

Perfect timing for sensory processing

Identification of brain regions involved in processing sights and sounds may offer insights into disorders like autism and dyslexia.

By VUMC News and Communications
May 10, 2012

Probing epilepsy’s molecular sparks

Understanding how mutations in neuronal receptors contribute to epilepsy could lead to improved therapies.
By Leigh MacMillan
May 2, 2012

Early stomach troubles augur anxiety

Children with stomach troubles grow up to be anxious adolescents and young adults, according to a recent study.
By VUMC News and Communications
April 30, 2012

Better blood pressure-reducing drugs?

A newer version of an old class of blood pressure lowering drugs may offer advantages for obese patients with metabolic syndrome.
By Leigh MacMillan
April 27, 2012

Dengue antibodies give vaccine leads

New information may help speed development of a vaccine or treatment for dengue fever.
By VUMC News and Communications
April 26, 2012

New drug mutes more melanomas

An experimental melanoma drug may be beneficial for patients not eligible for targeted therapies.
By VUMC News and Communications
April 20, 2012

Neuronal clues to cholesterol-defect disorder

Antioxidants may be a beneficial treatment for an inherited genetic disorder.
By Leigh MacMillan
April 17, 2012

Pathways to delirium in the ICU

Study suggests that the “kynurenine” biochemical pathway could be a target for reducing delirium and coma in critically ill patients.
By Leigh MacMillan
1 … 77 78 79 80 81 … 92